Oral Answers to Questions Debate
Full Debate: Read Full DebateJo Churchill
Main Page: Jo Churchill (Conservative - Bury St Edmunds)Department Debates - View all Jo Churchill's debates with the Department of Health and Social Care
(5 years ago)
Commons ChamberWe are world leading in genomics and should celebrate that. A recent trial at Addenbrooke’s Hospital in Cambridge provided whole genome sequencing, identifying underlying genetic conditions for babies and children in intensive care. As a result, three quarters of those young patients received changes to their care. The NHS genomic service is working to embed genomics in routine healthcare. Later this year, the national genomic healthcare strategy will set out the ambitious programme for the next 10 years.
With increasing direct-to-consumer genomic testing by private companies, can my hon. Friend advise what assessment has been made of the potential impact of self-referrals on NHS services?
Patients who need a genomic test from the national genomic test directory will be referred to the NHS genomic medicine service. However, I recognise that some patients may contact their GP for advice after taking a commercial test. NHS England is working with partners to ensure that GPs receive training to help them respond correctly. Public Health England and the National Screening Committee have also published guidance on private screening.
Health service professionals in the Black Country are concerned that the removal of local funding for in-house molecular testing for cancer in April in favour of regional genomic laboratory hubs could in certain circumstances cause delays in diagnosis and be more expensive. Will the Minister look at this again in order to refine the processes to address these particular issues?
Clinicians should be in charge of the process, and I have been assured that the change, using genomic testing, is better for patients and better for outcomes, but I would of course be happy to meet the hon. Gentleman and discuss it further.
I commend the Minister for the progressive approach the Government have taken to genomics, but for a large number of genetic diseases the symptoms do not manifest themselves until after developmental damage has been done. Will the Government consider whether we should extend genomic testing to all neonates—all newborns—at some point in the future?
The Government are very open to such an approach. Genomics is transformative, and the early detection of disease means that we can treat patients from birth better and more efficiently.
Surely all this must be put in the context of the Topol review, with so much innovation and not just in genomics? There is so much innovation going on in the health service, but we have to make sure that there are well-managed and efficient hospital trusts running these programmes. Many are not like Huddersfield and are not up to speed, and we have to get hospitals up to speed in using the new technologies.
I totally agree with the hon. Gentleman, and my constituency neighbour, the Secretary of State, is totally on this programme.
In January, the Secretary of State announced that genomic testing would be provided in NHS England to healthy subjects for a few hundred pounds. This ill-advised plan, which would have widened health inequalities, seems to have gone quiet, so can the Minister confirm that the Government no longer plan to sell genetic testing and genomic testing in NHS England?
As the hon. Lady knows, because we have worked together on this agenda, it is never about selling the product; it is about better patient care and ensuring that we get technology to the patient as speedily as we can for better and appropriate diagnosis.
Cancer survival rates are, thankfully, at a record high. Last year, the NHS carried out 53 million diagnostic tests, which is 53% higher than the number carried out in 2010, but we need to do more. Our aim is to diagnose three quarters of all cancers early, so that 55,000 more people each year survive cancer for another five years. To achieve that, we are radically overhauling screening programmes to improve access and uptake, investing £200 million in diagnostic equipment and accelerating the adoption of the most innovative cancer treatments.
I thank my hon. Friend for all the work he does to make sure people are aware of cancer screening and taking it up. Diagnosing bowel cancer early is vital if we are to beat this disease. We have committed to lowering the age of bowel cancer screening from 60 to 50 and we rolled out the fit bowel screening test in June. It is easier to use and is expected to improve uptake by 70% in towns like Dudley. Sir Mike Richards’ screening review sets out important recommendations, using prioritisation of evidence-based incentives. We will set out our plan for implementing it next year, so that people can access screening more accessibly—in car parks or wherever else it suits their lifestyle—and we can save more lives.
Access to screening is a function of people’s poverty. For example, in Newcastle, cervical screening rates vary from 85% to 23%. A Macmillan Cancer Support report said clearly that we need to have access to screening in the places where people are, particularly for those who are running two jobs and so on. What is the Minister specifically doing to make screening available where people are?
I agree with the hon. Lady on this. The Richards review and working through the recommendations will enable us to put more screening in places where people can access it. The Eve Appeal, specifically directed at cervical cancer, is looking to put screening in workplaces and so on, but anybody who is worried must get tested.
The Secretary of State is absolutely right in his intent to put the one-year cancer survival metric at the very heart of the cancer strategy, to encourage earlier diagnosis, which the all-party parliamentary group on cancer has long campaigned for. Will the Government ensure that adequate funding is attached to the metric, so that we can finally start closing the gap on international survival rates?
I thank my hon. Friend for all his work leading the all-party parliamentary group on cancer. We are putting more money into diagnostic tests, which means that there will be more than 7.9 million more tests. Making sure that we have the correct data on survivability, in which the one-year test is an important metric, is part of that programme.
In the past year, more than 34,000 cancer patients have waited beyond two months for treatment. Every single waiting time measure for cancer has worsened in the past year. Surely, the Minister should be ashamed that so many more cancer patients are waiting longer for treatment.
I probably know as well as most that waiting for a cancer diagnosis is traumatic and that it needs to be done as speedily as possible. There is nothing more frightening than that wait, so what have we done? In 2018, 2.2 million people were seen by a specialist for suspected cancer—that is more than 1.2 million more people per annum since 2010. Getting to the specialist an individual needs as quickly as possible is what this Government are focused on, and that is why we have put so much emphasis on having specialist clinical nurses in the cancer workforce. We will carry on making cancer a priority.
But the problem is that that is not happening, is it? Cancer patients are waiting longer for treatment. In recent weeks, we have had an avalanche of hospital board papers blaming understaffing and George Osborne’s pension tax changes for the deterioration in waiting time standards. The Prime Minister promised to fix Osborne’s pension tax mess. How many more patients need to be added to the waiting list before it is fixed?
The guidance for doctors’ pensions was changed last month. As I said, making sure that everybody can access a GP as soon as they are worried and then get to a specialist as soon as possible is our top priority, and making sure we have a broad-based cancer workforce is part of that plan. Delivering these things, as well as rapid diagnostic centres with £200 million in new machinery, is how we are going to do it.
Absolutely; I thank my right hon. Friend for putting it so eloquently. This just shows what can be achieved. We have seen great results from the soft drinks industry levy. The average sugar content of drinks subject to the levy decreased by 28.8% between 2015 and 2018, so we have been able to make significant investments in activity and healthy eating in schools.
Mr Speaker, as this is the last time that we will have Health questions with you in the Chair, I want to thank you for being a fantastic Speaker—particularly through your support for Back Benchers and ensuring that we can be heard through urgent questions.
Last week, we found that the number of people receiving publicly-funded social care has fallen by 15,000 in the past year. We know that 95 people a day die while waiting for care and that cuts of £7.7 billion have been made from social care budgets since 2010. Older and disabled people are paying the price. Labour has set out our plans to deliver free personal care for people aged over 65 who need it. We are providing dignity in old age. When will the Secretary of State give people the dignity and care they deserve, and bring forward the Government’s plans for social care?
Digitising the process by using electronic prescribing will save the national health service up to £300 million, freeing up vital time for GPs and pharmacists to spend with their patients. It will start on 19 November.
That was part of the prevention Green Paper. We have the consultation responses, which we will assess and come forward with proposals.
There is still too much reliance on body mass index as an indicator of good health in sufferers of eating disorders. Will the Secretary of State get behind the “Dump the Scales” campaign and meet the indomitable campaigner Hope Virgo, to ensure that GPs realise there is more to eating disorders than just weight?
I am delighted to echo that again in the context of the fact that next month, November, is Lung Cancer Awareness Month. I ask my right hon. Friend to commend the Roy Castle Lung Cancer Foundation and all those who are highlighting the signs of this disease to save lives, quite literally, because of the need for early diagnosis. Equally, could he update the House on the lung health checks programme, which is targeted screening that could quite literally save lives from this terrible disease?
Along with my right hon. Friend, I pay tribute to the Roy Castle Lung Cancer Foundation, but also to all the charities that work in the cancer space and do the most tremendous work on awareness raising, because it is only by awareness raising that we can actually get earlier diagnoses and beat this disease. We are looking very seriously at what my right hon. Friend suggests.
May I thank you, Mr Speaker, for all the support you have given to Select Committees during your time in the Chair?
After a long period of engagement with patients, staff and partner organisations, the NHS has come up with a clear set of recommendations to the Government and Parliament for the legislative reforms it needs. I hope all political parties are listening to that. Will the Secretary of State confirm that he will accept all its recommendations, including the one that recommends scrapping section 75 of the Health and Social Care Act 2012 and other provisions, which would end wasteful contracting rounds in the NHS?
Will the Secretary of State speak to his colleagues in the Home Office and get them to allow Glasgow City health and social care partnership to open a supervised drug consumption room in my constituency and get vulnerable people into a service that will keep them alive?
We currently have no plans to change the law on drug consumption rooms. We support a range of evidence-based approaches to reducing the health-related harms associated with drug misuse. I keenly await the summit in Glasgow, which will focus on tackling problem drug use and bring together the experts we need. Dame Carol Black’s report is out in the next few weeks, but putting better resources into treatment and recovery is vital and I urge the Scottish Government to invest.
Will the Secretary of State visit Wycombe Hospital to discuss the future of our increasingly tired 1960s tower block?